Table 1 Published reports of incidental concurrent findings during RRP and lymph node dissections for PCa

Donohue et al. 1996 [5, 6]

225 (N.A.)

3 (1.2%)

Lymphoma NOS

N.A.

Terris et al. 1997 [7]

1092 (all patients)

13 (1.2%)

3 HL

Pelvic and abdominal external beam irradiation

1 HCL

Aggressive tp NOS

1 CLL

No tp

6 SLL

No tp

Eisenberger et al. 1999 [8]

4319 (all patients)

10 (0.2%)

8 Lymphocytic lymphoma

Single-agent CT

2 FL

N.A

Winstanley et al. 2002 [9]

1001 (854)

15 (1.8%)

2 SLL/CLL

N.A.

3 neoplastic (0.003%)

1 FL

N.A.

12 Non-neoplastic findings¹

N.A.

Weir et al. 2003 [10]

6143 (all patients)

18 (0.3%)

18 SLL/CLL

N.A.

He et al. 2007 [11]

1500 (1150)

13 (1.13%)

9 SLL/CLL

N.A.

3 MZL

N.A.

1 MCL

Aggressive CT NOS

Chu et al. 2005 [12]

4831³ (N.A.)

29 (0.6%)

18 incidental cases

N.A.

13 SLL/CLL

N.A.

3 MZL

1 MCL

11 concurrent known lymphoma²

4 SLL/CLL

4 FL

2 MCL

1 DLBCL

Isolated case reports

Encountered Hematolymphoid malignancy

Treatment required for hematologic malignancy

Carson H et al. 1996 [13]

1 SLL/CLL

N.A

Mydlo et al. 2001 [14]

1 lymphoma NOS

N.A

Drinis et al. 2009 [15]

1 SLL/CLL

No tp